Equities

Astec Lifesciences Ltd

Astec Lifesciences Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)1,170.15
  • Today's Change-10.40 / -0.88%
  • Shares traded7.36k
  • 1 Year change-22.04%
  • Beta0.5450
Data delayed at least 15 minutes, as of May 18 2024 07:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Astec LifeSciences Limited is an India-based company that is primarily engaged in manufacturing a range of agrochemical active ingredients and pharmaceutical intermediates. The Company operates through the Agrochemicals segment. It manufactures a range of fungicides, insecticides, herbicides, and intermediates for its global customers. The Company’s products and intermediates includes triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, thorium salts, pyrazalone’s and heterocyclic sulfonyl chlorides.

  • Revenue in INR (TTM)4.58bn
  • Net income in INR-469.30m
  • Incorporated1994
  • Employees551.00
  • Location
    Astec Lifesciences LtdGodrej One, 3rd Floor, Pirojshanagar,, EMUMBAI 400079IndiaIND
  • Phone+91 2 225188010
  • Fax+91 2 222618289
  • Websitehttps://www.astecls.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Panama Petrochem Ltd.21.26bn1.85bn20.17bn156.0010.90--10.370.948630.5830.58351.50--------136,292,900.00--13.51--23.5417.0920.038.708.39--16.13--18.175.4610.811.1430.7513.7746.14
Madhya Bharat Agro products Ltd8.17bn248.45m20.21bn308.0081.205.7637.512.472.842.8493.8940.051.062.654.24--3.2111.395.6618.1431.7833.313.049.250.7862.570.45244.09-16.8147.74-80.0016.79137.8731.95
Gocl Corporation Ltd7.69bn570.72m20.28bn222.0035.52--29.412.6411.5211.52155.23--------34,656,330.00--4.51--5.3123.0127.617.4219.41---0.1333--17.8384.8413.1419.9144.00-1.0625.59
Vishnu Chemicals Ltd12.48bn1.09bn20.32bn422.0017.52--14.481.6317.7017.70200.84--------29,577,610.00--7.30--12.9430.0535.318.736.53--4.62--2.8030.1216.3567.7856.7728.8614.87
Sigachi Industries Ltd3.67bn494.13m21.64bn1.03k44.86--36.875.891.471.4711.07--------3,551,738.00--18.15--24.6352.7849.4313.4515.12--10.02--0.0020.6824.438.7449.6487.10--
Yasho Industries Ltd5.93bn579.34m21.68bn659.0037.337.3629.473.6550.9450.94521.75258.540.72232.515.32--7.059.0510.3215.6635.9333.649.768.350.59625.650.6627---11.6111.78-14.6337.2658.12--
IOL Chemicals and Pharmaceuticals Ltd.21.33bn1.34bn21.96bn2.56k16.331.3611.131.0322.9022.90363.33274.490.99983.724.37--6.3014.918.2719.4534.5034.796.3012.001.2410.410.0199---3.804.82-3.39-10.7035.27--
Bhagiradha Chemicals and Industries Ltd4.19bn203.95m22.01bn467.0092.06--70.745.251.921.9238.89--------8,971,398.00--8.84--14.3838.8525.764.876.84--5.12----15.2521.8826.31--26.58--
Foseco India Ltd4.89bn745.94m22.49bn225.0030.15--27.104.60116.80116.80765.70------------13.76--19.8245.7539.2615.2511.35--671.05--32.9117.385.6858.7717.909.290.00
Astec LifeSciences Limited4.58bn-469.30m23.15bn551.00--6.27--5.05-23.94-23.94234.09188.320.46891.302.83---4.804.71-9.109.7330.3230.66-10.236.380.5102-1.670.572---27.061.24-283.57--20.75--
India Glycols Ltd74.98bn1.71bn24.51bn1.28k14.32--8.910.326855.2655.262,421.80--------58,398,440.00--3.79--6.6610.5610.732.282.71--2.85--12.440.60959.80-62.055.3227.6413.40
Tatva Chintan Pharma Chem Ltd3.94bn303.54m25.73bn608.0082.653.4945.996.5413.3113.31171.88315.100.49891.105.10--3.8510.544.8214.6155.7446.397.7114.431.826.520.0195.17-7.1113.79-33.278.1267.37--
Premier Explosives Limited2.37bn240.15m25.83bn822.00107.63--73.6110.8922.3222.32220.46--------2,886,219.00--0.159--0.229262.0347.0210.140.2542--3.67----1.46-6.3430.32-3.25-1.93-7.42
Thirumalai Chemicals Ltd20.83bn-387.90m27.08bn526.00--2.36110.921.30-3.79-3.79203.73111.900.73345.8414.61---1.375.26-2.057.5220.1226.26-1.865.640.8583-0.2920.52219.92-2.3010.56-143.18--33.22-12.94
Data as of May 18 2024. Currency figures normalised to Astec Lifesciences Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

8.32%Per cent of shares held by top holders
HolderShares% Held
ICICI Prudential Asset Management Co. Ltd.as of 30 Apr 2024715.99k3.65%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 30 Apr 2024468.59k2.39%
Motilal Oswal Asset Management Co. Ltd.as of 30 Sep 2023197.80k1.01%
Norges Bank Investment Managementas of 31 Dec 2023187.18k0.96%
Dimensional Fund Advisors LPas of 04 Apr 202443.69k0.22%
ITI Asset Management Ltd. (India)as of 30 Apr 202411.75k0.06%
SSgA Funds Management, Inc.as of 04 Apr 20244.33k0.02%
Dimensional Fund Advisors Ltd.as of 29 Feb 20241.91k0.01%
DFA Australia Ltd.as of 31 Dec 2023269.000.00%
More ▼
Data from 31 Dec 2023 - 09 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.